MiR-1224-5p attenuates polycystic ovary syndrome through inhibiting NOD-like receptor protein 3 inflammasome activation via targeting Forkhead box O 1

References

• Norman RJ, Dewailly D, LEGRO RS, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–697.
   PubMed Web of Science ®Google Scholar
• GOODARZI MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219–231.
   PubMed Web of Science ®Google Scholar
• DUNAIF A. Insulin resistance in polycystic ovary syndrome. Ann N Y Acad Sci. 1993;687:60-4.
   Google Scholar
• Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223–1236.
   PubMed Web of Science ®Google Scholar
• SIRMANS SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014;6:1–13.
   Web of Science ®Google Scholar
• GONZ LEZ F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77:300–305.
   PubMed Web of Science ®Google Scholar
• He Y, HARA H, N Ez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41:1012–1021.
   PubMed Web of Science ®Google Scholar
• Lee H-M, Kim -J-J, Kim HJ, et al. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62:194–204.
   PubMed Web of Science ®Google Scholar
• NAVARRO-PANDO JM, ALCOCER-G MEZ E, Castej N-vega B, et al. Inhibition of the NLRP3 inflammasome prevents ovarian aging. Sci Adv. 2021;7. DOI:10.1126/sciadv.abc7409
   PubMed Web of Science ®Google Scholar
• Wang D, WENG Y, ZHANG Y, et al. Exposure to hyperandrogen drives ovarian dysfunction and fibrosis by activating the NLRP3 inflammasome in mice. Sci Total Environ. 2020a;745:141049.
   PubMed Web of Science ®Google Scholar
• SAMIE KA, TABANDEH MR, Afrough M. Betaine ameliorates impaired steroidogenesis and apoptosis in mice granulosa cells induced by high glucose concentration. Syst Biol Reprod Med. 2020;66:400–409.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li C, Ali I, et al. N-acetylcysteine modulates non-esterified fatty acid-induced pyroptosis and inflammation in granulosa cells. Mol Immunol. 2020b;127:157–163.
   PubMed Web of Science ®Google Scholar
• LIU Y, LIU H, Li Z, et al. The release of peripheral immune inflammatory cytokines promote an inflammatory cascade in PCOS patients via altering the follicular microenvironment. Front Immunol. 2021;12:685724.
   PubMed Web of Science ®Google Scholar
• GUO Q-J, Shan J, Xu Y-F, et al. Pioglitazone metformin complex improves polycystic ovary syndrome comorbid psychological distress via inhibiting NLRP3 inflammasome activation: a prospective clinical study. Mediators Inflamm. 2020;2020(2020):1–7.
   Google Scholar
• Kim DH, Kim SM, Lee B, et al. Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome. J Nutr Biochem. 2017;45:104–114.
   PubMed Web of Science ®Google Scholar
• KAUR S, Archer KJ, Devi MG, et al. Differential gene expression in granulosa cells from polycystic ovary syndrome patients with and without insulin resistance: identification of susceptibility gene sets through network analysis. J Clin Endocrinol Metab. 2012;97:E2016–E2021.
   PubMed Web of Science ®Google Scholar
• Wu J, Wu Y, ZHANG X, et al. Elevated serum thioredoxin‐interacting protein in women with polycystic ovary syndrome is associated with insulin resistance. Clin Endocrinol (Oxf). 2014;80:538–544.
   PubMed Web of Science ®Google Scholar
• Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376–385.
   PubMed Web of Science ®Google Scholar
• CALIN GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866.
   PubMed Web of Science ®Google Scholar
• Abe M, BONINI NM. MicroRNAs and neurodegeneration: role and impact. Trends Cell Biol. 2013;23:30–36.
   PubMed Web of Science ®Google Scholar
• ROTTIERS V, N R AM. MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol. 2012;13:239–250.
   PubMed Web of Science ®Google Scholar
• SORENSEN AE, WISSING ML, Sal S, et al. MicroRNAs related to polycystic ovary syndrome (PCOS). Genes (Basel). 2014;5:684–708.
   PubMed Web of Science ®Google Scholar
• YAO L, Li M, HU J, et al. MiRNA-335-5p negatively regulates granulosa cell proliferation via SGK3 in PCOS. Reproduction. 2018;156:439–449.
   PubMed Web of Science ®Google Scholar
• AZHARY JMK, HARADA M, KUNITOMI C, et al. Androgens increase accumulation of advanced glycation end products in granulosa cells by activating ER stress in PCOS. Endocrinology. 2020;161. DOI:10.1210/endocr/bqaa015
   PubMed Web of Science ®Google Scholar
• DI EMIDIO G, REA F, PLACIDI M, et al. Regulatory functions of L-Carnitine, Acetyl, and Propionyl L-Carnitine in a PCOS mouse model: focus on antioxidant/antiglycative molecular pathways in the ovarian microenvironment. Antioxidants (Basel). 2020;9(9):867.
   Google Scholar
• EMIDIO GD, PLACIDI M, REA F, et al. Methylglyoxal-dependent glycative stress and deregulation of SIRT1 functional network in the ovary of PCOS mice. Cells. 2020;9(1):209.
   PubMed Web of Science ®Google Scholar
• KESKIN M, KURTOGLU S, KENDIRCI M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics. 2005;115:e500–e503.
   PubMed Web of Science ®Google Scholar
• Huang Y, YU Y, Gao J, et al. Impaired oocyte quality induced by dehydroepiandrosterone is partially rescued by metformin treatment. PLoS One. 2015;10:e0122370.
   PubMed Web of Science ®Google Scholar
• Deng J, Wang W, YU G, et al. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma. Mol Med Rep. 2019;20:4023–4032.
   PubMed Web of Science ®Google Scholar
• RASHAD NM, ATEYA MA, SARAYA YS, et al. Association of miRNA - 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome. J Ovarian Res. 2019;12:39.
   PubMed Web of Science ®Google Scholar
• SCHOPPEE PD, GARMEY JC, VELDHUIS JD. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod. 2002;66:190–198.
   PubMed Web of Science ®Google Scholar
• VILLAVICENCIO A, GOYENECHE A, TELLERIA C, et al. Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome. Gynecol Oncol. 2009;115:102–107.
   PubMed Web of Science ®Google Scholar
• KAI Y, KAWANO Y, YAMAMOTO H, et al. A possible role for AMP-activated protein kinase activated by metformin and AICAR in human granulosa cells. Reprod Biol Endocrinol. 2015;13:27.
   PubMed Web of Science ®Google Scholar
• Sasson R, Winder N, KEES S, et al. Induction of apoptosis in granulosa cells by TNF alpha and its attenuation by glucocorticoids involve modulation of Bcl-2. Biochem Biophys Res Commun. 2002;294:51–59.
   PubMed Web of Science ®Google Scholar
• YANG D, Wang Y, ZHENG Y, et al. Silencing of lncRNA UCA1 inhibited the pathological progression in PCOS mice through the regulation of PI3K/AKT signaling pathway. J Ovarian Res. 2021;14:48.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, Tu L, ZHOU X, et al. MicroRNA-22 regulates the proliferation, drug sensitivity and metastasis of human glioma cells by targeting SNAIL1. J buon. 2020;25:491–496.
   PubMed Web of Science ®Google Scholar
• Qiu Z, He Y, Ming H, et al. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:8151836.
   PubMed Web of Science ®Google Scholar
• Wang Q, ZHOU X, ZHAO Y, et al. Polyphyllin I ameliorates collagen-induced arthritis by suppressing the inflammation response in macrophages through the NF-κB pathway. Front Immunol. 2018;9:2091.
   PubMed Web of Science ®Google Scholar
• Han LC, Wang H, NIU FL, et al. Effect miR-214-3p on proliferation and apoptosis of breast cancer cells by targeting survivin protein. Eur Rev Med Pharmacol Sci. 2019;23:7469–7474.
   PubMed Web of Science ®Google Scholar
• GLINTBORG D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecological Endocrinol. 2010;26:281–296.
   PubMed Web of Science ®Google Scholar
• SALEHI M, Bravo-vera R, Sheikh A, et al. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism. 2004;53:358–376.
   PubMed Web of Science ®Google Scholar
• Chen Y-H, HENEIDI S, Lee J-M, et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance. Diabetes. 2013;62:2278–2286.
   PubMed Web of Science ®Google Scholar
• Roth LW, Mccallie B, ALVERO R, et al. Altered microRNA and gene expression in the follicular fluid of women with polycystic ovary syndrome. J Assist Reprod Genet. 2014;31:355–362.
   PubMed Web of Science ®Google Scholar
• MOTTA AB. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010;119:105–111.
   PubMed Web of Science ®Google Scholar
• BENSON S, JANSSEN O, Hahn S, et al. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome. Brain Behav Immun. 2008;22:177–184.
   PubMed Web of Science ®Google Scholar
• DELIGEOROGLOU E, Vrachnis N, ATHANASOPOULOS N, et al. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecological Endocrinol. 2012;28:974–978.
   PubMed Web of Science ®Google Scholar
• BORST SE. The role of TNF-α in insulin resistance. Endocrine. 2004;23:177–182.
   PubMed Web of Science ®Google Scholar
• Jo E-K, Kim JK, Shin D-M, et al. Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2016;13:148–159.
   PubMed Web of Science ®Google Scholar
• DE NARDO D, LATZ E. NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol. 2011;32:373–379.
   PubMed Web of Science ®Google Scholar
• Tan M-S, YU J-T, JIANG T, et al. The NLRP3 inflammasome in Alzheimer’s disease. Mol Neurobiol. 2013;48:875–882.
   PubMed Web of Science ®Google Scholar
• Lang Q, YIDONG X, XUEGUANG Z, et al. ETA-mediated anti-TNF-α therapy ameliorates the phenotype of PCOS model induced by letrozole. PloS One. 2019;14:e0217495.
   PubMed Web of Science ®Google Scholar
• GONZ LEZ F, Minium J, Rote NS, et al. Hyperglycemia alters tumor necrosis factor-α release from mononuclear cells in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:5336–5342.
   PubMed Web of Science ®Google Scholar
• Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117:421–426.
   PubMed Web of Science ®Google Scholar
• YOSHIHARA E, MASAKI S, MATSUO Y, et al. Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases. Front Immunol. 2014;4:514.
   PubMed Web of Science ®Google Scholar
• LIU Y, LIAN K, ZHANG L, et al. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol. 2014;109:415.
   PubMed Web of Science ®Google Scholar
• XIAO J, ZHU Y, LIU Y, et al. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway. Int J Biol Macromol. 2014;69:73–78.
   PubMed Web of Science ®Google Scholar
• ZHANG X, ZHANG J-H, Chen X-Y, et al. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation. Antioxid Redox Signal. 2015;22:848–870.
   PubMed Web of Science ®Google Scholar
• Li X, RONG Y, ZHANG M, et al. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun. 2009;381:660–665.
   PubMed Web of Science ®Google Scholar
• Baker RG, Hayden MS, GHOSH S. NF-κB, inflammation, and metabolic disease. Cell Metab. 2011;13:11–22.
   PubMed Web of Science ®Google Scholar
• TAK PP, FIRESTEIN GS. NF-κB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7–11.
   PubMed Web of Science ®Google Scholar
• MATSUMOTO M, Han S, KITAMURA T, et al. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J Clin Invest. 2006;116:2464–2472.
   PubMed Web of Science ®Google Scholar
• Samuel VT, CHOI CS, Phillips TG, et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes. 2006;55:2042–2050.
   PubMed Web of Science ®Google Scholar
• SU D, COUDRIET GM, Kim DH, et al. FoxO1 links insulin resistance to proinflammatory cytokine IL-1β production in macrophages. Diabetes. 2009;58:2624–2633.
   PubMed Web of Science ®Google Scholar
• ALTOMONTE J, Richter A, HARBARAN S, et al. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. Am J Physiol Endocrinol Metab. 2003;285:E718–E728.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116:1793–1801.
   PubMed Web of Science ®Google Scholar